SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp. engages in the design, manufacture, and launch of rockets and spacecrafts. It provides satellite communication services. The company was founded by Elon Reeve Musk on March 14, 2002 and is headquartered in Hawthorne, CA.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is dominating market conversation following its historic IPO, with traders divided between FOMO-driven buying and warnings that the stock is severely overvalued compared to its current earnings. While many investors are positioning for long-term growth as part of the broader space economy, others are treating the debut as a highly volatile scalp play and speculating on an inevitable pullback as institutional liquidity rotates into the name.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently trending as investors weigh the impact of the high-profile SpaceX debut alongside its own recent inclusion in the Nasdaq-100 index. Community discourse is sharply divided between those who believe the broader space sector is undergoing a massive structural revaluation and those who fear that speculative capital is rotating out of secondary proxies and into SpaceX, creating short-term volatility.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech 100 is seeing high volatility as investors weigh its exposure to SpaceX, Anthropic, and OpenAI against the implications of an ongoing ATM offering and broader market rotation. Community sentiment is deeply divided, with many debating whether the stock is a strategic opportunity to acquire private assets at a discount to potential NAV, or if the stock is facing selling pressure as market participants shift capital toward direct exposure to the upcoming SpaceX IPO.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is currently trending as the community debates a potential turning point following the resolution of a fee dispute with Publicis. While some investors view the settlement as a catalyst for a short squeeze and long-term recovery, others remain skeptical, citing persistent negative sentiment, executive turnover, and the stock's inability to maintain momentum.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is seeing significant volatility as market liquidity rotates into the high-profile SpaceX IPO, causing a sector-wide pullback despite upcoming satellite launch catalysts. While some investors are concerned about potential sector drag and aggressive institutional selling, others view the sharp decline as a strategic buying opportunity for a long-term play on direct-to-device broadband technology.

Tema ETF Trust - Tema Space Innovators ETF

Tema Space Innovators ETF

Investors are aggressively piling into the Tema Space Innovators ETF (NASA) as a proxy play for the highly anticipated SpaceX IPO, though the fund is seeing significant price volatility as capital rotates into the main event. Community members remain polarized, with many viewing the recent dips as a strategic buying opportunity in a sector they believe has long-term growth potential, while others fear the ETF could face short-term selling pressure from IPO-driven liquidity shifts.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending as investors react to positive Phase 1 clinical data for subcutaneous Briumvi in myasthenia gravis and a concurrent initiation of a Phase 2 trial. The stock is seeing high social media volume fueled by speculation about a potential buyout and community optimism regarding Briumvi's expanding market potential.

EchoStar Corp. engages in the design, development, and distribution of digital set-top boxes and products for direct-to-home satellite service providers. It operates through the following business segments: Pay-TV, Retail Wireless, and Broadband and Satellite Services. The Pay-TV segment business strategy is to be the best provider of video services in the United States by providing products with the best technology, outstanding customer service, and great value. The Retail Wireless segment offers Retail Wireless services as well as a competitive portfolio of wireless devices. The Broadband and Satellite Services segment business strategy is to maintain and improve leadership position and competitive advantage through development of technologies and services marketed to selected sectors within the consumer, enterprise and government markets globally. The company was founded by Charlie William Ergen, Candy Ergen, and James DeFranco in 1980 and is headquartered in Englewood, CO.

EchoStar Corp - Ordinary Shares - Class A

EchoStar Corp

EchoStar is currently in focus as investors analyze the stock's significant indirect exposure to the upcoming SpaceX IPO, viewing it as a potential value proxy for the space sector. Community sentiment is deeply divided between long-term holders betting on the revaluation of EchoStar's satellite assets and SpaceX stake, and short-sellers who are expressing concerns over the company's debt load and capital structure.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending as the company officially kicks off public R2 deliveries and opens orders for reservation holders, sparking intense debate among investors over pricing strategies and long-term profitability. While the community is split between bullish sentiment over positive R2 reviews and concerns regarding the stock's recent volatility and management's communication style, active discussions are centered on whether this launch represents a "Model 3 moment" for the company.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is generating significant community interest as investors weigh the ongoing $110 billion Warner Bros. Discovery merger against a brewing antitrust challenge from a coalition of U.S. states. While the community remains divided over the deal's complex financial structure and regulatory timeline, discourse is heavily focused on the company's aggressive integration of AI in streaming operations, potential asset divestitures to secure global approvals, and the strategic push to compete with major streaming rivals.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BELLUS Health is focused on developing drugs for rare diseases, starting with conditions that affect the kidneys. The lead program KIACTAâ?¢, a novel drug candidate, is in data review after announcing on June 20, 2016 top-line results from its Phase 3 study for the treatment of AA amyloidosis, a rare disease resulting in renal dysfunction that often leads to dialysis and death. BELLUS Health is partnered with global private equity firm Auven Therapeutics for the development of KIACTAâ?¢. KIACTAâ?¢ is also being developed as a treatment in a second indication called sarcoidosis, a rare, potentially fatal inflammatory condition that affects the lungs. An investigational new drug application (IND) for a Phase 2/3 clinical study is expected to be filed with the U.S. Food and Drug Administration in 2016. In addition, BELLUS Health is developing Shigamabâ?¢, an antibody treatment for Hemolytic Uremic Syndrome caused by Shiga toxin-producing E. coli (sHUS). sHUS often leads to dialysis, chronic kidney disease and in some cases death, particularly in children. Shigamabâ?¢ pre-clinical studies for the treatment of sHUS are currently underway.  BELLUS Healthâ??s pipeline also includes a research-stage project for the treatment of AL amyloidosis, a rare disease in which amyloid protein builds up and causes dysfunction in various parts of the body.

BLUBellus Health Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BLU News